| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.35% | +1.46% | - | - | 86.2M | ||
| +0.13% | +2.65% | +63.34% | +115.27% | 1,055B | ||
| +0.20% | +0.46% | +50.92% | +72.63% | 654B | ||
| -0.29% | +0.14% | +19.82% | +72.62% | 467B | ||
| -0.85% | +0.98% | +42.13% | +42.98% | 348B | ||
| +0.71% | +4.08% | +21.75% | +29.57% | 275B | ||
| +1.23% | +0.42% | +14.11% | +12.90% | 258B | ||
| +2.11% | +7.51% | +51.88% | +54.14% | 224B | ||
| +0.83% | +0.55% | +34.64% | +99.77% | 187B | ||
| 0.00% | -10.14% | -27.40% | -60.93% | 171B | ||
| Average | +0.64% | +0.74% | +30.13% | +48.77% | 404.26B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.43% | +68.66% |
Employees
18
Sector
Pharmaceuticals
















